<DOC>
	<DOCNO>NCT01609140</DOCNO>
	<brief_summary>The purpose study evaluate safety cholesterol lower effect MPSK3169A give subcutaneous ( SC ) injection 24-week period patient high risk cardiovascular event LDL-c level well goal .</brief_summary>
	<brief_title>A Phase II Study Safety Efficacy MPSK3169A Patients With Coronary Heart Disease High Risk Coronary Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Use standardofcare statin stable dose , intolerance statin , without use lipid modifying therapy Fasting LDL cholesterol 90250 mg/dL statin regimen And least one following : Coronary heart disease ( CHD ) history myocardial infarction ( MI ) , percutaneous coronary intervention ( PCI ) , coronary artery bypass graft surgery ( CABG ) , prior coronary angiography demonstrate coronary atherosclerosis A CHD risk equivalent condition , include diabetes mellitus ( type 1 2 ) , chronic kidney disease , prior stroke , carotid disease , peripheral arterial disease , abdominal aortic aneurism &gt; /=2 CHD risk factor ( age &gt; /= 45 year men &gt; /= 55 year woman ; smoke ; hypertension ; low HDL cholesterol ; family history premature CHD ) high risk CV event base risk estimation system Severe congestive heart failure ( NYHA Class IIIIV ) leave ventricular ejection fraction &lt; /= 35 % Recent ( within 3 month ) MI , unstable angina , stroke , transient ischemic attack , CABG , PCI , hospital admission heart failure , major surgery , uncontrolled cardiac arrhythmia ( atrial fibrillation flutter ) , initiation renal replacement therapy ( dialysis ) Fasting serum triglyceride level &gt; /= 400 mg/dL Homozygous familial hypercholesterolemia Poorly control diabetes mellitus , hypertension thyroid disease Liver muscle disease , include abnormal test result screen Pregnant lactate The list intend contain factor relevant patient 's eligibility study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Dyslipidemia</keyword>
</DOC>